25 Aug 2017 07:00
SCAPA GROUP PLC
PDMR Notification
25 August 2017
Notification and public disclosure of transactions by persons discharging managerial responsibilities ('PDMR') and persons closely associated with them ('PCA')
Scapa Group plc (AIM: SCPA), a global supplier of bonding solutions and manufacturer of adhesive-based products for the Healthcare and Industrial markets, announces that it was notified on 24 August 2017 of the exercise and subsequent sale of certain options under the 2011 Performance Share Plans ('PSP') by PDMRs of the Company, as set out below.
In addition, the Company announces that it has issued 912,865 new ordinary shares of 5 pence each in the capital of the Company ('Ordinary Shares') pursuant to the exercise of options under the 2011 Performance Share Plans ('PSP') by PDMRs of the Company. The Shares have been admitted to trading on AIM in accordance with the Company's block listing.
The Company advises that, following the issue of the new Ordinary Shares pursuant to the exercise of options under the PSP, the Company's issued share capital is 153,274,453. No Ordinary Shares are held in treasury. As such, the number of Ordinary Shares with voting rights is 153,274,453. This figure may be used by shareholders as their denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.
This announcement, including the notifications below, is made in accordance with the requirements of the EU Market Abuse Regulation.
ANNEX
1 | Details of the person discharging managerial responsibilities / person closely associated
| |
a) | Name | Heejae Chae
|
2 | Reason for the notification
| |
a) | Position / status | Chief Executive Officer
|
b) | Initial notification / amendment | Initial notification
|
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |
a) | Name | Scapa Group plc
|
b) | LEI
| 213800QIPVTK5ES5UU36 |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
| |
a) | Description of financial instrument, type of instrument | Ordinary Shares of 5p each |
| Identification Code
| GB0007281198 |
b) | Nature of the transaction | Exercise of share option and sale of shares
|
c) | Price(s) and volume(s)
| Exercise of share option: 336,364 shares for nil consideration Sale of 336,364 shares at 454.9356p per share. |
d) | Aggregated information - Aggregated volume - Price |
n/a |
e) | Date of the transaction
| 24 August 2017 |
f) | Place of the transaction
| London |
1 | Details of the person discharging managerial responsibilities / person closely associated
| |
a) | Name | Joseph Davin
|
2 | Reason for the notification
| |
a) | Position / status | President, Healthcare Business Unit
|
b) | Initial notification / amendment | Initial notification
|
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |
a) | Name | Scapa Group plc
|
b) | LEI
| 213800QIPVTK5ES5UU36 |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
| |
a) | Description of financial instrument, type of instrument | Ordinary Shares of 5p each |
| Identification Code
| GB0007281198 |
b) | Nature of the transaction | Exercise of share option and sale of shares
|
c) | Price(s) and volume(s)
| Exercise of share option: 157,909 shares for nil consideration Sale of 157,909 shares at 454.9356p per share. |
d) | Aggregated information - Aggregated volume - Price |
n/a |
e) | Date of the transaction
| 24 August 2017 |
f) | Place of the transaction
| London |
1 | Details of the person discharging managerial responsibilities / person closely associated
| |
a) | Name | Christopher Carter
|
2 | Reason for the notification
| |
a) | Position / status | Chief Operating Officer
|
b) | Initial notification / amendment | Initial notification
|
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |
a) | Name | Scapa Group plc
|
b) | LEI
| 213800QIPVTK5ES5UU36 |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
| |
a) | Description of financial instrument, type of instrument | Ordinary Shares of 5p each |
| Identification Code
| GB0007281198 |
b) | Nature of the transaction | Exercise of share option and sale of shares
|
c) | Price(s) and volume(s)
| Exercise of share option: 81,955 shares for nil consideration Sale of 81,955 shares at 454.9356p per share. |
d) | Aggregated information - Aggregated volume - Price |
n/a |
e) | Date of the transaction
| 24 August 2017 |
f) | Place of the transaction
| London |
1 | Details of the person discharging managerial responsibilities / person closely associated
| |
a) | Name | Sayoung Jung
|
2 | Reason for the notification
| |
a) | Position / status | MD, Global Corp Dev & Strategy
|
b) | Initial notification / amendment | Initial notification
|
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |
a) | Name | Scapa Group plc
|
b) | LEI
| 213800QIPVTK5ES5UU36 |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
| |
a) | Description of financial instrument, type of instrument | Ordinary Shares of 5p each |
| Identification Code
| GB0007281198 |
b) | Nature of the transaction | Exercise of share option and sale of shares
|
c) | Price(s) and volume(s)
| Exercise of share option: 122,727 shares for nil consideration Sale of 122,727 shares at 454.9356p per share. |
d) | Aggregated information - Aggregated volume - Price |
n/a |
e) | Date of the transaction
| 24 August 2017 |
f) | Place of the transaction
| London |
For further information:
Scapa Group plc:
Graham Hardcastle +44 (0) 161 301 7400
Group Finance Director/Company Secretary
Numis Securities Limited: +44 (0) 20 7260 1000
Mark Lander/ Richard Thomas
(Joint Broker/Nominated Adviser)
Berenberg +44 (0) 20 3207 7800
Chris Bowman
(Joint Broker)